Robert O. Kraft
Robert O. Kraft's purchase track record
How the stock did after each of Robert O. Kraft's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/11/2026 | HLMN | $249K | pending | pending | — |
| 5/1/2025 | HLMN | $993K | +12.2% | +33.0% | +21.7% |
| 11/30/2022 | HLMN | $497K | +7.2% | +1.8% | +2.4% |
| 3/7/2022 | HLMN | $492K | +18.3% | -21.9% | -7.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
HLMN highlighted in recent articles as a risky small-cap stock. Recent market commentary has flagged Hillman Solutions as a potentially risky holding, citing concerns that may deter some investors. The stock is currently trading near its 52-week low, with technical indicators showing weakness and a rejection at key support levels. While analyst targets remain higher than the current price, the recent focus on risk factors suggests heightened scrutiny of the company's outlook.
Transaction History
| MEDP | ▲ Buy | Option Exercise | 32 | — | 9/30/2026 | View on chart |
| HLMN | ▲ Buy | Open Market | 35,500 | $249K | 9/11/2026 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 3,858 | $325K | 8/26/2026 | View on chart |
| MEDP | ▼ Sell | Open Market | 3,858 | $2.4M | 8/26/2026 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 33 | — | 6/30/2026 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 33 | — | 3/31/2026 | View on chart |
| HLMN | ▲ Buy | Grant | 46,068 | $0 | 3/7/2026 | View on chart |
| HLMN | ▼ Sell | Tax Withholding | 13,192 | $107K | 3/7/2026 | View on chart |
| HLMN | ▼ Sell | Tax Withholding | 4,038 | $33K | 3/7/2026 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 56 | — | 12/31/2025 | View on chart |
| MEDP | ▼ Sell | Open Market | 6,472 | $3.8M | 11/14/2025 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 6,472 | $356K | 11/14/2025 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 57 | — | 9/30/2025 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 57 | — | 6/30/2025 | View on chart |
| HLMN | ▲ Buy | Open Market | 140,000 | $993K | 5/1/2025 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 57 | — | 3/31/2025 | View on chart |
| HLMN | ▲ Buy | Grant | 39,267 | $0 | 3/7/2025 | View on chart |
| HLMN | ▼ Sell | Tax Withholding | 10,410 | $97K | 1/11/2025 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 71 | — | 12/31/2024 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 71 | — | 9/30/2024 | View on chart |
| HLMN | ▲ Buy | Grant | 157,894 | $0 | 9/7/2024 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 3,774 | $161K | 8/23/2024 | View on chart |
| MEDP | ▼ Sell | Open Market | 3,774 | $1.5M | 8/23/2024 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 4,353 | $186K | 8/22/2024 | View on chart |
| MEDP | ▼ Sell | Open Market | 4,353 | $1.7M | 8/22/2024 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 72 | — | 6/30/2024 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 72 | — | 3/31/2024 | View on chart |
| HLMN | ▲ Buy | Grant | 38,148 | $0 | 3/7/2024 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 94 | — | 12/31/2023 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 94 | — | 9/30/2023 | View on chart |
| MEDP | ▼ Sell | Open Market | 13,782 | $3.7M | 8/14/2023 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 13,782 | $364K | 8/14/2023 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 94 | — | 6/30/2023 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 94 | — | 3/31/2023 | View on chart |
| HLMN | ▲ Buy | Grant | 42,759 | $0 | 3/7/2023 | View on chart |
| HLMN | ▲ Buy | Open Market | 65,000 | $497K | 11/30/2022 | View on chart |
| MEDP | ▲ Buy | Option Exercise | 9,630 | $221K | 11/1/2022 | View on chart |
| MEDP | ▼ Sell | Open Market | 9,630 | $2.1M | 11/1/2022 | View on chart |
| HLMN | ▲ Buy | Open Market | 47,500 | $492K | 3/7/2022 | View on chart |
| HLMN | ▲ Buy | Grant | 30,181 | $0 | 1/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Medpace sees strong bookings but faces valuation and growth concerns
Recent analyst articles note that Medpace reported strong bookings, which support its technical momentum. At the same time, several pieces point out that the company's high valuation and flat pass‑through growth leave limited upside, and that a shorter, cleaner backlog may be misinterpreted as a smaller pipeline. These factors together shape the current market view of the stock.
Medpace sees strong bookings but faces valuation and growth concerns. Recent analyst articles note that Medpace reported strong bookings, which support its technical momentum. At the same time, several pieces point out that the company's high valuation and flat pass‑through growth leave limited upside, and that a shorter, cleaner backlog may be misinterpreted as a smaller pipeline. These factors together shape the current market view of the stock.